Related Experiment Video
Updated: May 27, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Brachytherapy for clinically localized prostate cancer: optimal patient selection
Marisa A Kollmeier1, Michael J Zelefsky
1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. kollmeim@mskcc.org
Archivos Espanoles De Urologia
|November 5, 2011
Summary
Prostate brachytherapy offers effective cancer treatment with high efficacy and low side effects. Optimal patient selection is crucial for maximizing benefits and minimizing toxicity from this radiation therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Prostate brachytherapy is increasingly used for localized prostate cancer.
- It offers conformal radiation, low morbidity, and high efficacy.
- It involves permanent radioactive seed implantation (low dose rate) or temporary iridium-192 catheters.
Purpose of the Study:
- To review prostate brachytherapy modalities.
- To guide optimal patient selection for these treatments.
- To discuss maximizing outcomes and minimizing toxicity.
Main Methods:
- Review of prostate brachytherapy techniques.
- Analysis of patient selection criteria.
- Comparison of treatment outcomes and toxicity.
Main Results:
- Prostate brachytherapy delivers targeted high radiation doses to the prostate.
- It minimizes radiation exposure to surrounding healthy tissues.
- It enables dose escalation beyond external beam radiotherapy.
Conclusions:
- Careful patient selection is critical for successful prostate brachytherapy.
- Optimizing patient candidacy enhances disease outcomes.
- Appropriate selection minimizes treatment-related toxicity.
